NCT00399542View on ClinicalTrials.gov

Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation

PHASE3CompletedINTERVENTIONAL
Enrollment

581

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Irritable Bowel SyndromeConstipation
Interventions
DRUG

Lubiprostone

DRUG

Placebo

All Listed Sponsors
collaborator

Sucampo Pharmaceuticals, Inc.

INDUSTRY

lead

Sucampo Pharma Americas, LLC

INDUSTRY

NCT00399542 - Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation | Biotech Hunter | Biotech Hunter